Pro Medicus Limited Stock
Stocks
PME
AU000000PME8
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
02:10:11 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 172.70 AUD | +0.16% |
|
-6.45% | -21.81% |
| 08-20 | Pro Medicus' Unit Signs AU$25 Million Contract With US Health System | MT |
| 08-18 | Australia shares end flat as BHP, CSL offset banks' decline | RE |
| Market Cap | 18.04B 12.94B 11.16B 10.52B 9.58B 17.91B 1,222B 124B 48.31B 625B 48.59B 47.52B 2,053B | P/E 2027 * |
96.2x | P/E 2028 * | 75.3x |
|---|---|---|---|---|---|
| Enterprise Value | 17.75B 12.73B 10.98B 10.34B 9.42B 17.62B 1,202B 122B 47.53B 615B 47.8B 46.75B 2,019B | EV / Sales 2027 * |
52.4x | EV / Sales 2028 * | 42x |
| Free-Float |
51.04% | Yield 2027 * |
0.55% | Yield 2028 * | 0.66% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PME | Delayed | |
Tradegate
| PMC | Real-time | |
|
OTC Markets
| PMCUF | Delayed | |
|
Boerse Muenchen
| PMC | Real-time | |
|
Deutsche Boerse AG
| PMC | Delayed |
Last Transcript : Pro Medicus Limited
| 1 day | +0.16% | ||
| 1 week | -6.45% | ||
| Current month | -3.73% | ||
| 1 month | +6.47% | ||
| 3 months | +7.88% | ||
| 6 months | +37.48% | ||
| Current year | -21.81% |
| 1 week | 169.14 |  | 187.16 |
| 1 month | 166.2 | | 209.39 |
| Current year | 107.75 | | 223.02 |
| 1 year | 107.75 | | 321.57 |
| 3 years | 70.67 | | 336 |
| 5 years | 36.54 | | 336 |
| 10 years | 4.27 | | 336 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Hupert
CEO | Chief Executive Officer | - | 2010-09-30 |
Anthony Hall
CTO | Chief Tech/Sci/R&D Officer | - | - |
Danny English
DFI | Director of Finance/CFO | - | 2026-03-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Hall
BRD | Director/Board Member | - | 1982-12-31 |
Peter Kempen
CHM | Chairman | 75 | 2010-07-31 |
Anthony Glenning
BRD | Director/Board Member | - | 2016-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/25/26 | Buy | Founder | 8,146 | 0.0078% | ||
| 2/25/26 | Buy | Founder | 9,000 | 0.0086% | ||
| 2/24/26 | Buy | Founder | 8,500 | 0.0081% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | -6.45% | -41.39% | +136.71% | 12.92B | |
| -0.46% | -1.27% | +2.81% | +26.70% | 45.45B | |
| +1.33% | +2.40% | -12.17% | +66.86% | 5.74B | |
| -1.63% | +1.46% | +56.01% | - | 4.35B | |
| +1.04% | +4.38% | - | - | 2.09B | |
| +0.78% | +4.82% | +6.70% | -40.86% | 1.58B | |
| -1.34% | -1.68% | -34.67% | - | 1.1B | |
| -4.29% | -1.38% | +52.06% | +60.80% | 992M | |
| +0.49% | -0.77% | +30.53% | +151.47% | 1.01B | |
| -3.07% | -0.29% | -32.75% | -46.62% | 825M | |
| Average | -0.70% | +1.28% | +3.01% | +50.72% | 7.6B | |
| Weighted average by Cap. | -0.40% | +8.09% | -2.78% | +50.69% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 339M 243M 210M 197M 180M 336M 22.94B 2.34B 907M 11.73B 912M 892M 38.53B | 420M 301M 260M 245M 223M 417M 28.45B 2.9B 1.12B 14.54B 1.13B 1.11B 47.77B |
| Net income | 186M 133M 115M 108M 98.59M 184M 12.58B 1.28B 497M 6.43B 500M 489M 21.12B | 239M 171M 148M 139M 127M 237M 16.18B 1.65B 640M 8.27B 643M 629M 27.17B |
| Net Debt | -293M -210M -181M -171M -156M -291M -19.87B -2.02B -785M -10.16B -790M -772M -33.37B | -405M -291M -251M -236M -215M -402M -27.44B -2.8B -1.08B -14.03B -1.09B -1.07B -46.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | A$172.70 | +0.16% | 212,138 |
| 26-09-02 | A$172.42 | -2.27% | 246,843 |
| 26-09-01 | A$176.42 | -1.66% | 175,444 |
| 26-08-31 | A$179.39 | -1.15% | 252,383 |
| 26-08-28 | A$181.48 | +1.25% | 223,412 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PME Stock
Select your edition
All financial news and data tailored to specific country editions
